Evidence-Based Management of Massive and Submassive Pulmonary Embolism
DOI:
https://doi.org/10.58877/japaj.v2i1.127Keywords:
pulmonary embolism, submassive, massive, high-risk, intermediate-risk, thrombolysis, catheter-directed therapy, supportive careAbstract
Acute pulmonary embolism (PE) can lead to life-threatening complications, such as shock due to right ventricular failure and death. PE cases can be stratified as low, intermediate, or high-risk. Intermediate-risk and high-risk PE present with right ventricular dysfunction and elevated cardiac troponins, but only high-risk PE is associated with hemodynamic instability. Although low-risk PE management is well-defined, that is not the case with intermediate and high-risk PEs. All PEs are initially managed with anticoagulation; systemic thrombolysis is the treatment of choice for high-risk ones. Treatment modalities such as reduced-dose thrombolysis, catheter-directed therapy (catheter-directed thrombolysis and mechanical thrombectomy), and surgical pulmonary embolectomy were explored in various trials. Despite this arsenal of treatments for PE, each modality carries risks and complications that further complicate PE management. Supportive care measures such as fluid management, vasopressors and inotropes, oxygen therapy, mechanical ventilation, and extracorporeal membrane oxygenation can mitigate clinical deterioration and hemodynamic collapse, especially in high-risk PE. This review provides an overview of acute PE presentation, diagnosis, risk stratification, and management while putting an emphasis on the diverse modalities of treatment and the studies exploring each.
References
Coon WW, Willis PW. Deep venous thrombosis and pulmonary embolism. Prediction, prevention and treatment*. Am J Cardiol. 1959;4(5). DOI: https://doi.org/10.1016/0002-9149(59)90145-6
Root CW, Dudzinski DM, Zakhary B, Friedman OA, Sista AK, Horowitz JM. Multidisciplinary approach to the management of pulmonary embolism patients: The pulmonary embolism response team (PERT). Vol. 11, Journal of Multidisciplinary Healthcare. 2018. DOI: https://doi.org/10.2147/JMDH.S151196
Gohil R, Peck G, Sharma P. The genetics of venous thromboembolism. A meta-analysis involving approximately 120,000 cases and 180,000 controls. Thromb Haemost [Internet]. 2009 Aug [cited 2023 Jul 24];102(2):360–70. Available from: https://pubmed.ncbi.nlm.nih.gov/19652888/ DOI: https://doi.org/10.1160/TH09-01-0013
Goldhaber SZ, Grodstein F, Stampfer MJ, Manson JAE, Colditz GA, Speizer FE, et al. A prospective study of risk factors for pulmonary embolism in women. JAMA. 1997;277(8). DOI: https://doi.org/10.1001/jama.1997.03540320044033
Anderson FA, Spencer FA. Risk factors for venous thromboembolism. Vol. 107, Circulation. 2003. DOI: https://doi.org/10.1161/01.CIR.0000078469.07362.E6
Haider A, Goldberg J. NATIONAL TRENDS IN PULMONARY EMBOLISM MANAGEMENT AND OUTCOMES: SHIFTING PARADIGMS. J Am Coll Cardiol. 2019;73(9). DOI: https://doi.org/10.1016/S0735-1097(19)32507-0
Horlander KT, Mannino DM, Leeper K V. Pulmonary embolism mortality in the United States, 1979-1998: An analysis using multiple-cause mortality data. Arch Intern Med. 2003;163(14). DOI: https://doi.org/10.1001/archinte.163.14.1711
Jha AK, Larizgoitia I, Audera-Lopez C, Prasopa-Plaizier N, Waters H, Bates DW. The global burden of unsafe medical care: Analytic modelling of observational studies. BMJ Qual Saf. 2013;22(10). DOI: https://doi.org/10.1136/bmjqs-2012-001748
Pulmonary Embolism: An International Crisis - Endovascular Today [Internet]. [cited 2023 Jul 24]. Available from: https://evtoday.com/articles/2019-july-supplement/pulmonary-embolism-an-international-crisis
Kumar DR, Hanlin ER, Glurich I, Mazza JJ, Yale SH. Virchow’s contribution to the understanding of thrombosis and cellular biology. Clin Med Res. 2010;8(3–4). DOI: https://doi.org/10.3121/cmr.2009.866
Bagot CN, Arya R. Virchow and his triad: A question of attribution. Vol. 143, British Journal of Haematology. 2008. DOI: https://doi.org/10.1111/j.1365-2141.2008.07323.x
Nakos G, Kitsiouli EI, Lekka ME. Bronchoalveolar lavage alterations in pulmonary embolism. Am J Respir Crit Care Med. 1998;158(5 PART I). DOI: https://doi.org/10.1164/ajrccm.158.5.9802036
Vyas V, Goyal A. Acute Pulmonary Embolism. 2022 Aug 8 [cited 2023 Jul 25]; Available from: https://www.ncbi.nlm.nih.gov/books/NBK560551/
Belenkie I, Dani R, Smith ER, Tyberg J V. Ventricular interaction during experimental acute pulmonary embolism. Circulation. 1988;78(3 I). DOI: https://doi.org/10.1161/01.CIR.78.3.761
Wood KE. Major pulmonary embolism: Review of a pathophysiologic approach to the golden hour of hemodynamically significant pulmonary embolism. Vol. 121, Chest. 2002. DOI: https://doi.org/10.1378/chest.121.3.877
Layish DT, Tapson VF. Pharmacologic hemodynamic support in massive pulmonary embolism. Vol. 111, Chest. 1997. DOI: https://doi.org/10.1378/chest.111.1.218
McIntyre KM, Sasahara AA. Determinants of right ventricular function and hemodynamics after pulmonary embolism. Chest. 1974;65(5). DOI: https://doi.org/10.1378/chest.65.5.534
Stein PD, Henry JW. Clinical characteristics of patients with acute pulmonary embolism stratified according to their presenting syndromes. Chest. 1997;112(4). DOI: https://doi.org/10.1378/chest.112.4.974
Thames MD, Alpert JS, Dalen JE. Syncope in Patients With Pulmonary Embolism. JAMA: The Journal of the American Medical Association. 1977;238(23). DOI: https://doi.org/10.1001/jama.1977.03280240055020
Islam M, Filopei J, Frank M, Ramesh N, Verzosa S, Ehrlich M, et al. Pulmonary infarction secondary to pulmonary embolism: An evolving paradigm. Respirology. 2018;23(9). DOI: https://doi.org/10.1111/resp.13299
Konstantinides S V., Meyer G, Galié N, Simon R Gibbs J, Aboyans V, Ageno W, et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Vol. 54, European Respiratory Journal. European Respiratory Society; 2019.
Kearon C. Diagnosis of pulmonary embolism. Vol. 168, CMAJ. Canadian Medical Association Journal. 2003.
Wells PS, Anderson DR, Rodger M, Stiell I, Dreyer JF, Barnes D, et al. Excluding pulmonary embolism at the bedside without diagnostic imaging: management of patients with suspected pulmonary embolism presenting to the emergency department by using a simple clinical model and d-dimer. Ann Intern Med [Internet]. 2001 Jul 17 [cited 2023 Jul 27];135(2):98–107. Available from: https://pubmed.ncbi.nlm.nih.gov/11453709/ DOI: https://doi.org/10.7326/0003-4819-135-2-200107170-00010
Ginsberg JS, Wells PS, Kearon C, Anderson D, Crowther M, Weitz JI, et al. Sensitivity and specificity of a rapid whole-blood assay for D-dimer in the diagnosis of pulmonary embolism. Ann Intern Med [Internet]. 1998 Dec 15 [cited 2023 Jul 27];129(12):1006–11. Available from: https://pubmed.ncbi.nlm.nih.gov/9867754/ DOI: https://doi.org/10.7326/0003-4819-129-12-199812150-00003
De Groot MR, Van Marwijk Kooy M, Pouwels JGJ, Engelage AH, Kuipers BF, Büller HR. The use of a rapid D-dimer blood test in the diagnostic work-up for pulmonary embolism: A management study. Thromb Haemost. 1999;82(6). DOI: https://doi.org/10.1055/s-0037-1614883
Pollack C V., Schreiber D, Goldhaber SZ, Slattery D, Fanikos J, O’Neil BJ, et al. Clinical characteristics, management, and outcomes of patients diagnosed with acute pulmonary embolism in the emergency department: Initial report of EMPEROR (multicenter emergency medicine pulmonary embolism in the real world registry). J Am Coll Cardiol. 2011 Feb 8;57(6):700–6.
Sista AK, Kuo WT, Schiebler M, Madoff DC. Stratification, imaging, and management of acute massive and submassive pulmonary embolism. Vol. 284, Radiology. Radiological Society of North America Inc.; 2017. p. 5–24. DOI: https://doi.org/10.1148/radiol.2017151978
Petruzzelli S, Palla A, Pieraccini F, Donnamaria V, Giuntini C. Routine electrocardiography in screening for pulmonary embolism. Respiration. 1986;50(4). DOI: https://doi.org/10.1159/000194933
Boey E, Teo SG, Poh KK. Electrocardiographic findings in pulmonary embolism. Singapore Med J. 2015;56(10). DOI: https://doi.org/10.11622/smedj.2015147
Geibel A, Zehender M, Kasper W, Olschewski M, Klima C, Konstantinides S V. Prognostic value of the ECG on admission in patients with acute major pulmonary embolism. European Respiratory Journal. 2005;25(5). DOI: https://doi.org/10.1183/09031936.05.00119704
Levis JT. ECG Diagnosis: Pulmonary Embolism. Perm J. 2011;15(4). DOI: https://doi.org/10.7812/tpp/11-112
Kasper W, Konstantinides S, Geibel A, Olschewski M, Heinrich F, Grosser KD, et al. Management strategies and determinants of outcome in acute major pulmonary embolism: Results of a multicenter registry. J Am Coll Cardiol. 1997;30(5). DOI: https://doi.org/10.1016/S0735-1097(97)00319-7
Fujita T. Outpatient treatment for pulmonary embolism. Vol. 378, The Lancet. 2011. DOI: https://doi.org/10.1016/S0140-6736(11)61732-7
Den Exter PL, Zondag W, Klok FA, Brouwer RE, Dolsma J, Eijsvoge M, et al. Efficacy and safety of outpatient treatment based on the hestia clinical decision rule with or without N-terminal pro-brain natriuretic peptide testing in patients with acute pulmonary embolism: A randomized clinical trial. Am J Respir Crit Care Med. 2016;194(8). DOI: https://doi.org/10.1164/rccm.201512-2494OC
Piran S, Le Gal G, Wells PS, Gandara E, Righini M, Rodger MA, et al. Outpatient treatment of symptomatic pulmonary embolism: A systematic review and meta-analysis. Thromb Res. 2013;132(5). DOI: https://doi.org/10.1016/j.thromres.2013.08.012
Maughan BC, Frueh L, McDonagh MS, Casciere B, Kline JA. Outpatient Treatment of Low-risk Pulmonary Embolism in the Era of Direct Oral Anticoagulants: A Systematic Review. Vol. 28, Academic Emergency Medicine. 2021. DOI: https://doi.org/10.1111/acem.14108
G A, HR B, A C, M C, AS G, M J, et al. Oral apixaban for the treatment of acute venous thromboembolism. N Engl J Med [Internet]. 2013 [cited 2023 Jul 24];369(9):25–6. Available from: https://pubmed.ncbi.nlm.nih.gov/23808982/
HR B, MH P, AW L, H D, BF J, E M, et al. Oral rivaroxaban for the treatment of symptomatic pulmonary embolism. N Engl J Med [Internet]. 2012 Jun [cited 2023 Jul 24];366(14). Available from: https://pubmed.ncbi.nlm.nih.gov/22449293/ DOI: https://doi.org/10.1056/NEJMoa1113572
Schulman S, Kakkar AK, Goldhaber SZ, Schellong S, Eriksson H, Mismetti P, et al. Treatment of acute venous thromboembolism with dabigatran or warfarin and pooled analysis. Circulation. 2014;129(7). DOI: https://doi.org/10.1161/CIRCULATIONAHA.113.004450
Schulman S, Kearon C, Kakkar AK, Mismetti P, Schellong S, Eriksson H, et al. Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism. New England Journal of Medicine. 2009;361(24). DOI: https://doi.org/10.1056/NEJMoa0906598
Edoxaban versus Warfarin for the Treatment of Symptomatic Venous Thromboembolism. New England Journal of Medicine. 2014;370(4). DOI: https://doi.org/10.1056/NEJMx130058
Jaff MR, McMurtry MS, Archer SL, Cushman M, Goldenberg N, Goldhaber SZ, et al. Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension. Circulation [Internet]. 2011 Apr 26 [cited 2023 Aug 18];123(16):1788–830. Available from: https://www.ahajournals.org/doi/abs/10.1161/cir.0b013e318214914f
Erkens PM, Prins MH. Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism. In: Cochrane Database of Systematic Reviews. John Wiley & Sons, Ltd; 2010. DOI: https://doi.org/10.1002/14651858.CD001100.pub3
Robertson L, Jones LE. Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for the initial treatment of venous thromboembolism. Vol. 2017, Cochrane Database of Systematic Reviews. John Wiley and Sons Ltd; 2017. DOI: https://doi.org/10.1002/14651858.CD001100.pub4
Prandoni P, Siragusa S, Girolami B, Fabris F. The incidence of heparin-induced thrombocytopenia in medical patients treated with low-molecular-weight heparin: A prospective cohort study. Blood. 2005;106(9):3049–54. DOI: https://doi.org/10.1182/blood-2005-03-0912
Kahn SR, de Wit K. Pulmonary Embolism. Solomon CG, editor. New England Journal of Medicine [Internet]. 2022 Jul 7;387(1):45–57. Available from: http://www.nejm.org/doi/10.1056/NEJMcp2116489 DOI: https://doi.org/10.1056/NEJMcp2116489
Kearon C, Akl EA, Ornelas J, Blaivas A, Jimenez D, Bounameaux H, et al. Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report. Chest. 2016 Feb 1;149(2):315–52. DOI: https://doi.org/10.1016/j.chest.2015.11.026
Kaufman JA, Barnes GD, Chaer RA, Cuschieri J, Eberhardt RT, Johnson MS, et al. Society of Interventional Radiology Clinical Practice Guideline for Inferior Vena Cava Filters in the Treatment of Patients with Venous Thromboembolic Disease: Developed in collaboration with the American College of Cardiology, American College of Chest Physicians, American College of Surgeons Committee on Trauma, American Heart Association, Society for Vascular Surgery, and Society for Vascular Medicine. J Vasc Interv Radiol [Internet]. 2020 Oct 1 [cited 2023 Aug 18];31(10):1529–44. Available from: https://pubmed.ncbi.nlm.nih.gov/32919823/ DOI: https://doi.org/10.1016/j.jvir.2020.06.014
Jaff MR, McMurtry MS, Archer SL, Cushman M, Goldenberg N, Goldhaber SZ, et al. Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: A scientific statement from the american heart association. Circulation. 2011 Apr 26;123(16):1788–830. DOI: https://doi.org/10.1161/CIR.0b013e318214914f
Bikdeli B, Chatterjee S, Desai NR, Kirtane AJ, Desai MM, Bracken MB, et al. Inferior Vena Cava Filters to Prevent Pulmonary Embolism: Systematic Review and Meta-Analysis. J Am Coll Cardiol [Internet]. 2017 Sep 26 [cited 2023 Aug 18];70(13):1587–97. Available from: https://pubmed.ncbi.nlm.nih.gov/28935036/
Decousus H. Eight-year follow-up of patients with permanent vena cava filters in the prevention of pulmonary embolism: the PREPIC (Prevention du Risque d’Embolie Pulmonaire par Interruption Cave) randomized study. Circulation [Internet]. 2005 Jul 19 [cited 2023 Aug 18];112(3):416–22. Available from: https://pubmed.ncbi.nlm.nih.gov/16009794/ DOI: https://doi.org/10.1161/CIRCULATIONAHA.104.512834
Malhotra A, Kishore S, Trost D, Madoff DC, Winokur RS. Inferior Vena Cava Filters and Prevention of Recurrent Pulmonary Embolism. Semin Intervent Radiol [Internet]. 2018 Jun 1 [cited 2023 Aug 18];35(2):105–7. Available from: https://pubmed.ncbi.nlm.nih.gov/29872245/ DOI: https://doi.org/10.1055/s-0038-1642038
Venous thromboembolic diseases: diagnosis, management and thrombophilia testing NICE guideline. 2020 [cited 2023 Jul 25]; Available from: www.nice.org.uk/guidance/ng158
Meyer G, Vicaut E, Danays T, Agnelli G, Becattini C, Beyer-Westendorf J, et al. Fibrinolysis for Patients with Intermediate-Risk Pulmonary Embolism A BS TR AC T. N Engl J Med. 2014;370:1402–13. DOI: https://doi.org/10.1056/NEJMoa1302097
Yilmaz ES, Uzun O. Low-dose thrombolysis for submassive pulmonary embolism. Journal of Investigative Medicine. 2021;69(8). DOI: https://doi.org/10.1136/jim-2021-001816
Surgit O, Güner A, Türkmen İ, Kahraman S, Serbest NG, Güner EG, et al. Low-dose thrombolytic therapy versus unfractionated heparin in patients with intermediate-high risk pulmonary embolism. Ulusal Travma ve Acil Cerrahi Dergisi. 2023;29(6). DOI: https://doi.org/10.14744/tjtes.2023.55236
Amini S, Bakhshandeh H, Mosaed R, Abtahi H, Sadeghi K, Mojtahedzadeh M. Efficacy and Safety of Different Dosage of Recombinant Tissue-type Plasminogen Activator (rt-PA) in the Treatment of Acute Pulmonary Embolism: A Systematic Review and Meta-analysis. Iranian Journal of Pharmaceutical Research. 2021;20(2).
Sanchez O, Charles-Nelson A, Ageno W, Barco S, Binder H, Chatellier G, et al. Reduced-Dose Intravenous Thrombolysis for Acute Intermediate-High-risk Pulmonary Embolism: Rationale and Design of the Pulmonary Embolism International THrOmbolysis (PEITHO)-3 trial. Thromb Haemost. 2022;122(5). DOI: https://doi.org/10.1055/a-1653-4699
Piazza G, Hohlfelder B, Jaff MR, Ouriel K, Engelhardt TC, Sterling KM, et al. A Prospective, Single-Arm, Multicenter Trial of Ultrasound-Facilitated, Catheter-Directed, Low-Dose Fibrinolysis for Acute Massive and Submassive Pulmonary Embolism The SEATTLE II Study. 2015. DOI: https://doi.org/10.1016/j.jcin.2015.04.020
Tapson VF, Sterling K, Jones N, Elder M, Tripathy U, Brower J, et al. A Randomized Trial of the Optimum Duration of Acoustic Pulse Thrombolysis Procedure in Acute Intermediate-Risk Pulmonary Embolism: The OPTALYSE PE Trial. JACC Cardiovasc Interv. 2018 Jul 23;11(14):1401–10. DOI: https://doi.org/10.1016/j.jcin.2018.04.008
Kuo WT, Banerjee A, Kim PS, Frank ;, Demarco J, Levy JR, et al. Pulmonary Embolism Response to Fragmentation, Embolectomy, and Catheter Thrombolysis (PERFECT): Initial Results from a Prospective Multicenter Registry Running title: Initial Results from the Multicenter PERFECT Registry [Internet]. Vol. 73, Journal Subject Codes. Available from: http://journal.publications.chestnet.org/
Kucher N, Boekstegers P, Müller OJ, Kupatt C, Beyer-Westendorf J, Heitzer T, et al. Randomized, controlled trial of ultrasound-assisted catheter-directed thrombolysis for acute intermediate-risk pulmonary embolism. Circulation. 2014 Jan 28;129(4):479–86. DOI: https://doi.org/10.1161/CIRCULATIONAHA.113.005544
Siddiqi F, Odrljin TM, Fay PJ, Cox C, Francis CW. Binding of Tissue-Plasminogen Activator to Fibrin: Effect of Ultrasound. Blood. 1998 Mar 15;91(6):2019–25. DOI: https://doi.org/10.1182/blood.V91.6.2019.2019_2019_2025
Francis CW, Blinc A, Lee S, Cox C. Ultrasound accelerates transport of recombinant tissue plasminogen activator into clots. Ultrasound Med Biol [Internet]. 1995 [cited 2023 Aug 17];21(3):419–24. Available from: https://pubmed.ncbi.nlm.nih.gov/7645133/ DOI: https://doi.org/10.1016/0301-5629(94)00119-X
Avgerinos ED, Jaber W, Lacomis J, Markel K, Mcdaniel M, Rivera-Lebron BN, et al. Randomized Trial Comparing Standard Versus Ultrasound-Assisted Thrombolysis for Submassive Pulmonary Embolism The SUNSET sPE Trial. 2021 [cited 2023 Aug 19]; Available from: https://doi.org/10.1016/j.jcin.2021.04.049 DOI: https://doi.org/10.1016/j.jcin.2021.04.049
Sun B, Yang JX, Wang ZK, Zhou HJ, Chu Y, Li Y, et al. Clinical efficacy and safety of ultrasound-assisted thrombolysis vs. standard catheter-directed thrombolysis in patients with acute pulmonary embolism: A study level meta-analysis of clinical trials. Front Cardiovasc Med [Internet]. 2022 Oct 5 [cited 2023 Aug 19];9. Available from: /pmc/articles/PMC9581227/ DOI: https://doi.org/10.3389/fcvm.2022.967786
Kucher N. Catheter embolectomy for acute pulmonary embolism. Chest. 2007;132(2). DOI: https://doi.org/10.1378/chest.07-0665
Skaf E, Beemath A, Siddiqui T, Janjua M, Patel NR, Stein PD. Catheter-Tip Embolectomy in the Management of Acute Massive Pulmonary Embolism. Vol. 99, American Journal of Cardiology. 2007. DOI: https://doi.org/10.1016/j.amjcard.2006.08.052
Chechi T, Vecchio S, Spaziani G, Giuliani G, Giannotti F, Arcangeli C, et al. Rheolytic thrombectomy in patients with massive and submassive acute pulmonary embolism. Catheterization and Cardiovascular Interventions. 2009;73(4). DOI: https://doi.org/10.1002/ccd.21858
Tu T, Toma C, Tapson VF, Adams C, Jaber WA, Silver M, et al. A Prospective, Single-Arm, Multicenter Trial of Catheter-Directed Mechanical Thrombectomy for Intermediate-Risk Acute Pulmonary Embolism: The FLARE Study. JACC Cardiovasc Interv [Internet]. 2019 May 13 [cited 2023 Aug 19];12(9):859–69. Available from: https://pubmed.ncbi.nlm.nih.gov/31072507/ DOI: https://doi.org/10.1016/j.jcin.2018.12.022
Inci EK, Khandhar S, Toma C, Licitra G, Brown MJ, Herzig M, et al. Mechanical thrombectomy versus catheter directed thrombolysis in patients with pulmonary embolism: A multicenter experience. Catheterization and Cardiovascular Interventions [Internet]. 2023 Jan 1 [cited 2023 Aug 19];101(1):140–6. Available from: https://onlinelibrary.wiley.com/doi/full/10.1002/ccd.30505 DOI: https://doi.org/10.1002/ccd.30505
Kon ZN, Pasrija C, Bittle GJ, Vemulapalli S, Grau-Sepulveda M V., Matsouaka R, et al. The Incidence and Outcomes of Surgical Pulmonary Embolectomy in North America. Annals of Thoracic Surgery. 2019;107(5). DOI: https://doi.org/10.1016/j.athoracsur.2018.10.035
Keeling WB, Sundt T, Leacche M, Okita Y, Binongo J, Lasajanak Y, et al. Outcomes After Surgical Pulmonary Embolectomy for Acute Pulmonary Embolus: A Multi-Institutional Study. In: Annals of Thoracic Surgery. 2016. DOI: https://doi.org/10.1016/j.athoracsur.2016.05.004
Licha CRM, McCurdy CM, Maldonado SM, Lee LS. Current management of acute pulmonary embolism. Vol. 26, Annals of Thoracic and Cardiovascular Surgery. 2020. DOI: https://doi.org/10.5761/atcs.ra.19-00158
Kolkailah AA, Hirji S, Piazza G, Ejiofor JI, Ramirez Del Val F, Lee J, et al. Surgical pulmonary embolectomy and catheter-directed thrombolysis for treatment of submassive pulmonary embolism. J Card Surg [Internet]. 2018 May 1 [cited 2023 Aug 18];33(5):252–9. Available from: https://onlinelibrary.wiley.com/doi/full/10.1111/jocs.13576 DOI: https://doi.org/10.1111/jocs.13576
Kurnicka K, Lichodziejewska B, Goliszek S, Dzikowska-Diduch O, Zdończyk O, Kozłowska M, et al. Echocardiographic Pattern of Acute Pulmonary Embolism: Analysis of 511 Consecutive Patients. Journal of the American Society of Echocardiography [Internet]. 2016 Sep 1 [cited 2023 Aug 21];29(9):907–13. Available from: http://www.onlinejase.com/article/S0894731716301808/fulltext DOI: https://doi.org/10.1016/j.echo.2016.05.016
Stein PD, Hull RD, Matta F, Yaekoub AY, Liang J. Incidence of Thrombocytopenia in Hospitalized Patients with Venous Thromboembolism. American Journal of Medicine. 2009;122(10). DOI: https://doi.org/10.1016/j.amjmed.2009.03.026
Cossette B, Pelletier MÉ, Carrier N, Turgeon M, Leclair C, Charron P, et al. Evaluation of bleeding risk in patients exposed to therapeutic unfractionated or low-molecular-weight heparin: A cohort study in the context of a quality improvement initiative. Annals of Pharmacotherapy. 2010;44(6). DOI: https://doi.org/10.1345/aph.1M615
Kuo WT. Endovascular therapy for acute pulmonary embolism. Vol. 23, Journal of Vascular and Interventional Radiology. 2012. DOI: https://doi.org/10.1016/j.jvir.2011.10.012
Kuo WT, Gould MK, Louie JD, Rosenberg JK, Sze DY, Hofmann L V. Catheter-directed therapy for the treatment of massive pulmonary embolism: systematic review and meta-analysis of modern techniques. J Vasc Interv Radiol [Internet]. 2009 Nov [cited 2023 Jul 24];20(11):1431–40. Available from: https://pubmed.ncbi.nlm.nih.gov/19875060/ DOI: https://doi.org/10.1016/j.jvir.2009.08.002
Patel N, Patel NJ, Agnihotri K, Panaich SS, Thakkar B, Patel A, et al. Utilization of catheter-directed thrombolysis in pulmonary embolism and outcome difference between systemic thrombolysis and catheter-directed thrombolysis. Catheterization and Cardiovascular Interventions. 2015 Dec 1;86(7):1219–27. DOI: https://doi.org/10.1002/ccd.26108
Sukhija R, Aronow WS, Lee J, Kakar P, McClung JA, Levy JA, et al. Association of right ventricular dysfunction with in-hospital mortality in patients with acute pulmonary embolism and reduction in mortality in patients with right ventricular dysfunction by pulmonary embolectomy. American Journal of Cardiology. 2005;95(5). DOI: https://doi.org/10.1016/j.amjcard.2004.10.055
Konstantinides S V., Torbicki A, Agnelli G, Danchin N, Fitzmaurice D, Galiè N, et al. 2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism. Vol. 35, European Heart Journal. 2014. DOI: https://doi.org/10.1093/eurheartj/ehv131
Yavuz S, Toktas F, Goncu T, Eris C, Gucu A, Ay D, et al. Surgical embolectomy for acute massive pulmonary embolism. Int J Clin Exp Med. 2014;7(12).
Gorham LW. A Study of Pulmonary Embolism: Part I. A Clinicopathological Investigation of 100 Cases of Massive Embolism of the Pulmonary Artery; Diagnosis by Physical Signs and Differentiation from Acute Myocardial Infarction. Arch Intern Med. 1961;108(1). DOI: https://doi.org/10.1001/archinte.1961.03620070010003
Mercat A, Diehl JL, Meyer G, Teboul JL, Sors H. Hemodynamic effects of fluid loading in acute massive pulmonary embolism. Crit Care Med [Internet]. 1999 [cited 2023 Aug 14];27(3):540–4. Available from: https://pubmed.ncbi.nlm.nih.gov/10199533/ DOI: https://doi.org/10.1097/00003246-199903000-00032
Green EM, Givertz MM. Management of acute right ventricular failure in the intensive care unit. Curr Heart Fail Rep [Internet]. 2012 Sep [cited 2023 Aug 14];9(3):228–35. Available from: https://pubmed.ncbi.nlm.nih.gov/22805893/ DOI: https://doi.org/10.1007/s11897-012-0104-x
Ghignone M, Girling L, Prewitt RM. Volume expansion versus norepinephrine in treatment of a low cardiac output complicating an acute increase in right ventricular afterload in dogs. Anesthesiology [Internet]. 1984 [cited 2023 Aug 14];60(2):132–5. Available from: https://pubmed.ncbi.nlm.nih.gov/6198941/ DOI: https://doi.org/10.1097/00000542-198402000-00009
Manier G, Castaing Y. Influence of cardiac output on oxygen exchange in acute pulmonary embolism. Am Rev Respir Dis [Internet]. 1992 [cited 2023 Aug 14];145(1):130–6. Available from: https://pubmed.ncbi.nlm.nih.gov/1731576/ DOI: https://doi.org/10.1164/ajrccm/145.1.130
Lyhne MD, Dragsbaek SJ, Hansen J V., Schultz JG, Andersen A, Nielsen-Kudsk JE. Levosimendan, milrinone, and dobutamine in experimental acute pulmonary embolism. Pulm Circ. 2021;11(3). DOI: https://doi.org/10.1177/20458940211022977
Bhat T, Neuman A, Tantary M, Bhat H, Glass D, Mannino W, et al. Inhaled nitric oxide in acute pulmonary embolism: a systematic review. Rev Cardiovasc Med [Internet]. 2015 [cited 2023 Aug 14];16(1):1–8. Available from: https://pubmed.ncbi.nlm.nih.gov/25813791/ DOI: https://doi.org/10.3909/ricm0718
Lyhne MD, Hansen JV, Dragsbæk SJ, Mortensen CS, Nielsen-Kudsk JE, Andersen A. Oxygen Therapy Lowers Right Ventricular Afterload in Experimental Acute Pulmonary Embolism. Crit Care Med. 2021;49(9). DOI: https://doi.org/10.1097/CCM.0000000000005057
Aksakal A, Sağlam L, Kerget B, Yilmazel Uçar E. Comparison of the effectiveness of high-flow and conventional nasal cannula oxygen therapy in pulmonary embolism patients with acute hypoxemic respiratory failure. Tuberk Toraks. 2021;69(4). DOI: https://doi.org/10.5578/tt.20219604
Hobohm L, Sagoschen I, Habertheuer A, Barco S, Valerio L, Wild J, et al. Clinical use and outcome of extracorporeal membrane oxygenation in patients with pulmonary embolism. Resuscitation [Internet]. 2022 Jan 1 [cited 2023 Aug 14];170:285–92. Available from: https://pubmed.ncbi.nlm.nih.gov/34653550/ DOI: https://doi.org/10.1016/j.resuscitation.2021.10.007
Corsi F, Lebreton G, Bréchot N, Hekimian G, Nieszkowska A, Trouillet JL, et al. Life-threatening massive pulmonary embolism rescued by venoarterial-extracorporeal membrane oxygenation. Crit Care [Internet]. 2017 Mar 28 [cited 2023 Aug 14];21(1). Available from: https://pubmed.ncbi.nlm.nih.gov/28347320/ DOI: https://doi.org/10.1186/s13054-017-1655-8
Oh YN, Oh DK, Koh Y, Lim CM, Huh JW, Lee JS, et al. Use of extracorporeal membrane oxygenation in patients with acute high-risk pulmonary embolism: a case series with literature review. Acute and critical care [Internet]. 2019 [cited 2023 Aug 14];34(2):148–54. Available from: https://pubmed.ncbi.nlm.nih.gov/31723920/ DOI: https://doi.org/10.4266/acc.2019.00500
Rivera-Lebron B, McDaniel M, Ahrar K, Alrifai A, Dudzinski DM, Fanola C, et al. Diagnosis, Treatment and Follow Up of Acute Pulmonary Embolism: Consensus Practice from the PERT Consortium. Vol. 25, Clinical and Applied Thrombosis/Hemostasis. SAGE Publications Inc.; 2019. DOI: https://doi.org/10.1177/1076029619853037
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 JAPA Academy Journal
This work is licensed under a Creative Commons Attribution 4.0 International License.
